Isomorphic Labs raises $2.1B to advance AI drug design
Isomorphic Labs, a spinout from DeepMind, has successfully raised $2.1 billion in its second funding round, aided by prominent investors such as Thrive Capital, Alphabet, and several sovereign wealth funds.…
